BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 35138763)

  • 1. [The value of booster vaccination against COVID-19].
    van Lier PAC; Kalkman S
    Ned Tijdschr Geneeskd; 2021 Dec; 165():. PubMed ID: 35138763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 booster vaccine willingness.
    Sønderskov KM; Vistisen HT; Dinesen PT; Østergaard SD
    Dan Med J; 2021 Dec; 69(1):. PubMed ID: 34913428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A positive update on COVID-19 booster vaccine willingness among Danes.
    Sønderskov KM; Vistisen HT; Dinesen PT; Østergaard SD
    Dan Med J; 2022 Jan; 69(2):. PubMed ID: 35088699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years - United States, August 13, 2021-November 19, 2021.
    Fast HE; Zell E; Murthy BP; Murthy N; Meng L; Scharf LG; Black CL; Shaw L; Chorba T; Harris LQ
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(50):1735-1739. PubMed ID: 34914672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.
    Peeters M; Verbruggen L; Teuwen L; Vanhoutte G; Vande Kerckhove S; Peeters B; Raats S; Van der Massen I; De Keersmaecker S; Debie Y; Huizing M; Pannus P; Neven K; Ariën KK; Martens GA; Van Den Bulcke M; Roelant E; Desombere I; Anguille S; Goossens M; Vandamme T; van Dam P
    ESMO Open; 2021 Oct; 6(5):100274. PubMed ID: 34597941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021.
    Mbaeyi S; Oliver SE; Collins JP; Godfrey M; Goswami ND; Hadler SC; Jones J; Moline H; Moulia D; Reddy S; Schmit K; Wallace M; Chamberland M; Campos-Outcalt D; Morgan RL; Bell BP; Brooks O; Kotton C; Talbot HK; Lee G; Daley MF; Dooling K
    MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(44):1545-1552. PubMed ID: 34735422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
    Cornberg M; Buti M; Eberhardt CS; Grossi PA; Shouval D
    J Hepatol; 2021 Apr; 74(4):944-951. PubMed ID: 33563499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.
    Lopez Bernal J; Andrews N; Gower C; Robertson C; Stowe J; Tessier E; Simmons R; Cottrell S; Roberts R; O'Doherty M; Brown K; Cameron C; Stockton D; McMenamin J; Ramsay M
    BMJ; 2021 May; 373():n1088. PubMed ID: 33985964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current state of vaccination against SARS-CoV-2].
    Iking-Konert C; Specker C; Krüger K; Schulze-Koops H; Aries P
    Z Rheumatol; 2021 Mar; 80(2):158-164. PubMed ID: 33528655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune response after different SARS-CoV-2 vaccination regimens.
    Rose R; Neumann F; Grobe O; Lorentz T; Fickenscher H; Krumbholz A
    BMC Med; 2022 Jan; 20(1):31. PubMed ID: 35057798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days.
    Xu QY; Xue JH; Xiao Y; Jia ZJ; Wu MJ; Liu YY; Li WL; Liang XM; Yang TC
    Front Immunol; 2021; 12():786554. PubMed ID: 35003104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021.
    de Gier B; Andeweg S; Backer JA; ; Hahné SJ; van den Hof S; de Melker HE; Knol MJ;
    Euro Surveill; 2021 Nov; 26(44):. PubMed ID: 34738514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding a national increase in COVID-19 vaccination intention, the Netherlands, November 2020-March 2021.
    Sanders JG; Spruijt P; van Dijk M; Elberse J; Lambooij MS; Kroese FM; de Bruin M
    Euro Surveill; 2021 Sep; 26(36):. PubMed ID: 34505565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19.
    Li Q; Wang J; Tang Y; Lu H
    Drug Discov Ther; 2021; 15(3):118-123. PubMed ID: 34234059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Second Shot of CoronaVac Vaccine May Cause Reduction of Antibody Levels in People who Previously had COVID-19].
    Topkaya AE; Keskin AÜ; Dalan AB; Çıragil P
    Mikrobiyol Bul; 2022 Jan; 56(1):139-142. PubMed ID: 35088968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collective Action: The Medical College of Wisconsin COVID-19 Vaccination Program.
    Sanchez AM; Busse K; MacKinnon K; Henk L; MacKinnon GE; Brown J; Mauermann S; Dobrowski T; Jungmann J; Bultman J; Singh S; Nattinger AB
    WMJ; 2021 Dec; 120(4):305-308. PubMed ID: 35025179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient.
    Hill JA; Ujjani CS; Greninger AL; Shadman M; Gopal AK
    Cancer Cell; 2021 Aug; 39(8):1037-1038. PubMed ID: 34242571
    [No Abstract]   [Full Text] [Related]  

  • 20. Dutch Perspectives Toward Governmental Trust, Vaccination, Myths, and Knowledge About Vaccines and COVID-19.
    Yousuf H; van der Linden S; van Essen T; Gommers D; Scherder E; Narula J; Hofstra L
    JAMA Netw Open; 2021 Dec; 4(12):e2140529. PubMed ID: 34967887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.